Gaxos.ai Inc. (NASDAQ: GXAI) has acquired a 19.99% stake in America First Defense, a U.S.-based defense technology company developing next-generation drone and robotics platforms. The investment expands Gaxos.ai's exposure to American-owned defense innovation and aligns with its strategy to build a diversified portfolio of AI-driven businesses across high-growth sectors.
America First Defense focuses on two key technologies: a detachable counter-drone system designed to neutralize hostile unmanned aerial vehicles (UAVs) through precise protocol-level cyber attacks, and a biomimetic soft robotics platform engineered for low-detection ground and subsurface operations. These technologies target demand from U.S. defense, homeland security, border security, maritime security, municipal safety, and critical infrastructure operators.
The acquisition represents a strategic move into the rapidly evolving defense technology sector, where artificial intelligence is increasingly critical for national security applications. Counter-drone systems have become particularly important as UAV technology becomes more accessible and potentially threatening to critical infrastructure and public safety. The biomimetic robotics platform addresses growing needs for stealth surveillance and reconnaissance capabilities in complex environments.
Gaxos.ai is a technology company focused on reshaping how people interact with artificial intelligence across everyday life and high-impact industries. The company describes itself as building a portfolio of AI-powered solutions designed to make advanced technology more practical, accessible, and transformative. Its growing portfolio spans defense, health and wellness, entertainment, and productivity sectors.
This investment comes at a time when defense technology is experiencing significant transformation, with traditional defense contractors increasingly partnering with or acquiring innovative technology firms. The move positions Gaxos.ai to participate in the growing market for AI-enhanced defense solutions while diversifying its business beyond consumer and commercial applications.
The latest news and updates relating to GXAI are available in the company's newsroom at https://ibn.fm/GXAI. The full press release about this acquisition can be viewed at https://ibn.fm/slWlZ. BioMedWire, which published the original announcement, is a specialized communications platform focusing on biotechnology, biomedical sciences, and life sciences sectors, operating as part of the Dynamic Brand Portfolio at IBN.
For investors and industry observers, this transaction highlights the increasing convergence of artificial intelligence and defense technology, particularly in areas like autonomous systems and cybersecurity. As nations worldwide invest in modernizing their defense capabilities, companies developing AI-driven solutions for security applications are attracting significant attention from both strategic investors and public markets.
